Orexo: Zubsolv Rx data

Research Update

2017-11-28

09:35

The market share (rolling 4 weeks average) for Zubsolv tablets reached 5.17%, as of the 17th of November. The market share based on the number of prescriptions was at 4.99%. On a monthly basis, the overall market for buprenorphine/naloxone based opioid addiction treatments showed a y/y growth rate of 8.9% (TRx) and 9.7% (quantity), as of the 17th of November.

KP

Klas Palin

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.